ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Palliative care in pancreatic cancer: effects on symptom burden, survival, and place of death.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Inpatient Palliative Care and Procedural Intensity in Patients with Hepatopancreatobiliary Cancers at the End of Life.Annals of surgical oncology · 2026Article
- Assessing the Impact of Specialist Palliative Care on Healthcare Utilisation at the End of Life Among Patients With Pancreatic Cancer: A Nationwide Register-Based Cohort Study.Cancer medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPancreatic cancer is often diagnosed at advanced stages with limited treatment options. Although palliative care (PC) improves symptom control and end-of-life outcomes, referrals are frequently delayed. We evaluated changes in symptom intensity and analyzed survival and place of death among patients referred to PC.
methodsWe conducted a retrospective study of adults diagnosed with pancreatic cancer between 2011 and 2024 at a tertiary care hospital. Patients were grouped by referral to PC. Data were extracted from electronic records. Symptom intensity was assessed using the Edmonton Symptom Assessment System (ESAS) at the first and second PC visits. Survival was analyzed with Kaplan-Meier curves, and alluvial plots illustrated changes in symptom burden.
resultsAmong 489 patients (median age 67), 69.5% were referred to PC. Only 8.8% had resectable tumors, and 49.7% had metastases, more common in the PC group (54.7% vs. 14.8%; p < 0.001). Pain and fatigue were the most intense symptoms at admission. Anxiety, depression, and nausea demonstrated a significant improvement in intensity at the second PC assessment. In locally advanced unresectable cancer, PC referral was associated with longer survival (188 vs. 58 days; p = 0.022). Patients receiving PC more often died at home (80.2% vs. 25.0%; p < 0.001).
conclusionOur findings demonstrate a reduction in symptom intensity-particularly pain and fatigue-after PC admission. Patients referred to PC were more likely to have advanced, unresectable disease. These results underscore the need to integrate PC earlier in the treatment course to provide more comprehensive, individualized, and compassionate care.
Indexed as
Identifiers
41359199What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.